Animal Experimental Models Used In The Study Of Psychiatric Diseases

Animal experimental models used for modelling psychiatric diseases and treatments are an indispensable tool. But it is impossible to construct a single animal model which demonstrates every aspect of a psychiatric disease. Thus partial models are preferred. The validity of models are examined for construct, face and prediction dimensions. This evaluation is used together with the similarity with human disease and is of vital importance in terms of obtaining findings that will contribute to clinical applications. Learned helplessness, forced swim tests and tail suspension test are traditional tools for modelling depression with good predictive but limited construct validity so research shifted away from them. In depression research, animal models focusing on basic formations such as anhedonia comes to the fore. Chronic mild stress (CMS) protocol is used to create anhedonia and dependent variables like sucrose preference, intracranial self-stimulation reward (ICSS) and progressive ratio reward are used to measure the anhedonia with good face and predictive validity. Anxiety models include high plus maze, operant conflict test and social interaction paradigms best used to determine drugs anxiolytic effects. Modeling schizophrenia is challenging. Complexity of positive, negative, and cognitive symptoms makes it harder to replicate. Pharmacological manipulations like dopaminergic or glutamatergic agents, brain lesion models, and genetic manupulation techniques have been developed in this area. Prepulse inhibition (PPI), latent inhibition, and working memory tests, while not fully valid, provide results similar to humans. Addiction research utilizes animal models that reflect the stages of binge/intoxication, withdrawal, and craving. Dependent variables such as intracranial self-stimulation threshold (ICSS) measurements, conditioned place preference (CPP), and stress-induced reinstatement are used to demonstrate how substance use escalates, how reward thresholds change, and why relapse occurs. These methods demonstrate strong predictive validity and provide experimental settings for testing new pharmacological interventions. In general, animal models provide an irreplaceable opportunity for investigating the neurobiological and behavioral mechanisms for psychiatric illness. Despite their partial validity, these models are indispensable for investigating etiology, identifying therapeutic targets, and guiding clinical research. Future studies with improved model designs and incorporated genetic and enviromental factors will increase the applicability to complex psychiatric conditions.